23andMe Licenses Its Own Drug Compound To Almirall
Posted by
www.biotecnika.org
Known for its ancestry DNA tests, the Silicon Valley firm 23andMe Inc.
has licensed an antibody developed by them, to a Spanish drugmaker,
Almirall, for the treatment of inflammatory diseases. This is the
first time 23andMe is licensing its own drug component and this deal
was announced by Almairall in a filing with Spanish regulators. […]
The post 23andMe Licenses Its Own Drug Compound To Almirall appeared
first on BioTecNika .
https://www.biotecnika.org/2020/01/23andme-licenses-its-own-drug-to-almirall-a-spanish-drugmaker/
Biotech News
Subscribe to:
Post Comments (Atom)
Post a Comment